Jade Biosciences, Inc.

Ownership Transactions Reported by 29 Insiders

Symbol
JBIO on Nasdaq
Industry
Pharmaceutical Preparations
Location
221 Crescent St., Building 23, Suite 105, Waltham, MA

Insiders trading volume in the past year

Jade Biosciences, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Sofinnova Venture Partners X, L.P. 10%+ Owner $73.3M Jul 2, 2021
David S. Grayzel Director $50.9M Jun 5, 2024
Fairmount Funds Management LLC Director, 10%+ Owner $48.1M Oct 6, 2025
Atlas Venture Fund XII, L.P. 10%+ Owner $45.4M Jul 15, 2022
Cormorant Asset Management, LP Former 10% Owner $39.6M Jul 2, 2021
Timothy P. Noyes CHIEF EXECUTIVE OFFICER, Director $5.62M May 16, 2024
Ra Capital Management, L.P. 10%+ Owner $3.44M Apr 28, 2025
Hunter Gillies Chief Medical Officer $1.5M Jun 13, 2024
Marinus Verwijs Chief Technical Officer $1.13M Jun 14, 2024
Timothy Pigot Chief Commercial Officer $923K Jan 22, 2024
Andrew James King Exhibit 24 - Power of Attorney Chief Scientific Officer & Head of Research and Development $917K Apr 28, 2025
George A. Eldridge Officer Title: Chief Financial Officer and Treasurer $597K Jun 14, 2024
Ralph Niven Chief Scientific Officer $591K Feb 5, 2024
Lawrence Otto Klein Director $229K Apr 29, 2025
Allison Dorval Director $205K Jun 5, 2024
Joshua Resnick Director $205K Jun 5, 2024
Mark T. Iwicki Director $205K Jun 5, 2024
Donald J. Santel Director $205K Jun 5, 2024
Habib J. Dable Director $205K Jun 5, 2024
Maha Katabi Director, 10%+ Owner $205K Jun 5, 2024
Tom Frohlich Chief Executive Officer, Director $44.4K +$44.4K May 16, 2025
Benjamin T. Dake Officer Title: President, Chief Operating Officer and Secretary $24.8K Jul 31, 2024
Erin Lavelle Director Apr 29, 2025
Jonathan Quick Exhibit 24 - Power of Attorney Senior Vice President, Finance and Treasurer Apr 28, 2025
Elizabeth Bekiroglu Exhibit 24 - Power of Attorney General Counsel and Corporate Secretary Apr 28, 2025
Christopher W. Cain Director Apr 29, 2025
Eric Dobmeier Director Apr 29, 2025
Hetal Kocinsky Chief Medical Officer Apr 28, 2025
Bradford D. Dahms Chief Financial Officer Jul 14, 2025

Recent Insider Transactions by Companies or Individuals for Jade Biosciences, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.